Company’s Option to Purchase. 5.1. Subject to Section 7.1, the Company shall have the first option to purchase all or any part of the Offered Shares for the consideration per share and on the terms and conditions specified in the Notice. The Company must exercise such option, no later than 15 days after such Notice is deemed under Section 11.4 hereof to have been delivered to it, by written notice to the Selling Holder.
Company’s Option to Purchase. The Company will have an option to purchase all of the Shares offered in the Notice for the price and on the terms specified in such Notice. The Company must exercise such option in full and by giving written notice to Purchaser no later than [***] days after receipt of such Notice. CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
Company’s Option to Purchase. Subject to Section 4.2, except in the event of a proposed Transfer that would result in a Change of Control (in which case only the Significant Investors shall have the right to purchase the Offered Shares), the Company shall have the first option to offer to purchase, for cash payable at the closing of such Transfer, all or any part of the Offered Shares. The Company may exercise such option, subject to approval by a majority of the disinterested members of the Board, no later than ten (10) days after such Transfer Notice is delivered, by delivering a written notice to the Prospective Selling Investor setting forth the Company’s offer to purchase the Offered Shares, including (i) the cash price per Share at which the Company is willing to purchase the Offered Shares and (ii) the maximum number of Offered Shares the Company is willing to purchase (the “Company Exercise Notice”). In the event the Company does not exercise its option within such 10-day period with respect to all of the Offered Shares, the Company shall, by the last day of such period, give written notice of that fact to the Significant Investors (the “Investor Notice”). The Investor Notice shall specify the number of Offered Shares that the Company has not offered to purchase (the “Remaining Shares”).
Company’s Option to Purchase. In the event that the State of New York in the future permits the corporate practice of medicine without need to resort to a Certificate of Need, or if, in the opinion of counsel to the Company, it otherwise becomes lawful in New York State for the Company to acquire and operate the medical practice of the P.C., the Company shall have the right to purchase the medical practice of the P.C. and the P.C. agrees to sell the medical practice of the P.C. to the Company. The purchase price shall be $100. In order to make meaningful the foregoing right, the P.C. agrees that any purchaser of the P.C. or transferee or other recipient of share thereof and any successor P.C. and shareholders thereof shall be bound by the provisions of this Paragraph and no sale of the P.C. or transfer of shares thereof shall be effective unless the purchaser or transferee acknowledges in writing his agreement to the provisions of this Paragraph.
Company’s Option to Purchase. (a) Subject to Section 4.6, the Company shall have the first option to purchase all or any part of the Offered Shares for the consideration per share and on the terms and conditions specified in the Notice. The Company must exercise such option, no later than 15 days after such Notice is deemed under Section 9(d) hereof to have been delivered to it, by written notice to the Selling Shareholder.
Company’s Option to Purchase. The Company shall have the right and option to purchase all or any of the Transferable Shares for the price and upon the other terms hereinafter provided. Such option may be exercised only by giving written notice to the Transferring Shareholder within thirty (30) days after the Notice Date, stating the number of Shares which the Company desires to purchase. Any purchase of Transferable Shares by the Company under this Section 2.1 shall be consummated within ninety (90) days after the Notice Date.
Company’s Option to Purchase. (i) The Company shall have the right, upon notice to the Selling Shareholder at any time within ten (10) Business Days after receipt of the Transfer Notice (the “Company Purchase Right Period”), to purchase all or any portion of the Offered Shares upon the same terms and conditions as set forth in the Transfer Notice (“Company Right of First Refusal”), and the Selling Shareholder shall, upon receipt of the notice of purchase from the Company, sell the Offered Shares to the Company pursuant to such terms. If the Company gives the Selling Shareholder notice that it desires to purchase such Offered Shares, then payment for the Offered Shares shall be by check or wire transfer, against allotment of the Offered Shares to be purchased, at a place agreed upon between the Company and the Selling Shareholder and at the time of the scheduled closing therefor, which shall be no later than thirty (30) Business Days after the Selling Shareholder’s receipt of the Company’s notice of purchase. Upon completion of the Transfer of the Offered Shares to the Company pursuant to this Section 6.3(a)(i), the Company shall procure that the Offered Shares are forthwith cancelled.
Company’s Option to Purchase. For the period commencing upon the occurrence of an event giving rise to an option to buy, as specified in Section 13.2, and continuing thereafter until thirty (30) days after the Company's receipt of notice of the event giving rise to the option, which notice is in substantial compliance with the provisions of Section 13.4, the Company shall have the option to purchase all, but not less than all, of the Affected Interest of a Transferring Holder, which option and right to purchase are at the applicable price and according to the terms and conditions provided in this Article 13. The Company may exercise its right and option to purchase by giving written notice to the Transferring Holder and to the other Members of its intention to exercise its right and option before the expiration of such thirty (30) day period. In no event shall the Transferring Holder vote, either by its appointed Governor or as a Member, on the question of whether the Company will elect to exercise its option.
Company’s Option to Purchase. For the 90-day period (the “Company’s Option Period”) commencing with the Company’s receipt (or deemed receipt) of the Trigger Notice, the Company (as determined by the Board) shall have the option (the “Company’s Trigger-Related Purchase Option”) to purchase all, and not less than all, of the Triggered Shareholder’s Shares. The Company’s Trigger- Related Purchase Option shall be deemed exercised upon delivery of written notice (the “Company’s Notice of Trigger-Related Exercise”) to the Triggered Shareholder (or the Triggered Shareholder’s personal representative or other successor if applicable) prior to the expiration of the Company’s Option Period.
Company’s Option to Purchase. From and after the Commencement Date but on or before the fifth anniversary of the Closing, the Company shall have the right and option to purchase all, but not less than all, of the outstanding Shares and Warrant, in the following manner:
